ResMed general counsel sells 400 shares at $255
Alpha Vantage · Kalkine · · AI-summarised by FinFlash
ResMed Inc.'s Global General Counsel and Secretary, Michael J. Rider, sold 400 shares of the company's common stock at $255 per share on October 23, 2026. This transaction was executed under a Rule 10b5-1 trading plan established on February 28, 2025. Following the sale, Rider's direct beneficial ownership in ResMed stands at 12,318 shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.